You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 10, October 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Viral Infections
 •Child Development
 •Neonatology and Infant Care
 •Pregnancy and Breast Feeding
 •Gastroenterology
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hepatitis C Prevalence in Children With Perinatal Human Immunodeficiency Virus Infection Enrolled in a Long-term Follow-up Protocol

Susan Schuval, MD; Russell B. Van Dyke, MD; Jane C. Lindsey, ScD; Paul Palumbo, MD; Lynne M. Mofenson, MD; James M. Oleske, MD; Joseph Cervia, MD; Andrea Kovacs, MD; Wayne N. Dankner, MD; Elizabeth Smith, MD; Barbara Nowak; Gregory Ciupak; Nancy Webb; Michelle Eagle; Dorothy Smith; Roslyn Hennessey; Melissa Goodman-Kerkau; Myron J. Levin, MD; for the Pediatric AIDS Clinical Trials Group Protocol 1028S Team

Arch Pediatr Adolesc Med. 2004;158:1007-1013.

Objective  To evaluate the prevalence of hepatitis C virus (HCV) infection in children with perinatal human immunodeficiency virus (HIV) infection.

Design  Cross-sectional substudy.

Setting  Multicenter study from 41 sites in the United States.

Patients  Children with perinatal HIV infection were randomly selected from a large, long-term, follow-up protocol.

Main Outcome Measure  Hepatitis C infection was defined as having positive test results on both HCV antibody and HCV RNA assays.

Results  Five hundred thirty children enrolled in the substudy; definitive HCV test results were available for 525 children. Eighty-three percent were of a minority race or ethnicity.They were equally distributed by sex, had a median age of 10.7 years, and were relatively healthy, with 75% having CD4+ lymphocyte counts greater than 500 cells/mm3. Eight of 525 children (1.5%; 95% confidence interval [CI], 0.7%-3.0%) infected with HIV were coinfected with HCV. In contrast, the rate of HCV infection in a serosurvey of more than 2700 children aged 6 to 11 years from the National Health and Nutrition Examination Survey was 0.2% (95% CI, 0.04%-0.6%). In our study, there were no differences between children coinfected with HIV and HCV and those without HCV infection in terms of demographic characteristics, CD4+ or CD8+ T-lymphocyte counts, HIV 1 RNA levels, preterm or mode of delivery, or liver disease; however, the number of children coinfected with HIV and HCV was small.

Conclusion  While HCV prevalence infection rates are low in children with perinatal HIV infection, they are 8 to 10 times higher than reported in HCV serosurveys of children in the United States.


Author Affiliations: Schneider Children’s Hospital, Long Island Jewish Medical Center, New Hyde Park, NY (Drs Schuval and Cervia); Tulane University Health Sciences Center, New Orleans, La (Dr Van Dyke); Statistical and Data Analysis Center, Harvard School of Public Health, Boston, Mass (Dr Lindsey); University of Medicine and Dentistry of New Jersey, Newark (Drs Oleske and Palumbo); National Institute of Child Health and Human Development, Rockville, Md (Dr Mofenson); University of Southern California Medical Center, Los Angeles, Calif (Dr Kovacs); PAREXEL International and Duke University Medical Center, Durham, NC (Dr Dankner); National Institute of Allergy and Infectious Diseases, Bethesda, Md (Dr Smith); Frontier Science and Technology Research Foundation, Amherst, NY (Dr Nowak, Mr Ciupak, and Ms Web) University of Florida Health Science Center, Jacksonville (Ms Eagle); University of Massachusetts Memorial Health Care, Worcester (Ms D. Smith); Westat, Inc, Rockville (Ms Hennessey); University of North Carolina Retrovirology Core Laboratory, Chapel Hill, NC (Ms Goodman-Kerkau); and the University of Colorado Health Sciences Center, Denver (Dr Levin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Coinfection With Hepatitis C Virus and Human Immunodeficiency Virus 1 in Children: Pathogenesis and Screening
Martin et al.
Arch Pediatr Adolesc Med 2005;159:598-599.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.